It seems the publication of the first whole cancer genome sequence is getting a good reception in hematology circles. This past Saturday at the 50th Annual Meeting of the American Society of Hematology, Dr. Tim Ley presented our AML sequencing work to a packed room of over 2000 people. In fact, there was such demand to see the talk that they scheduled a second time for Dr. Ley to give the talk so that all those that were turned away the first time could get a chance to see it. There is a lot of excitement in these oncology circles because the initiating events for many of these tumors are not known and an unbiased, whole-genome sequencing approach is currently the best chance to discover them.